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Background: Some people with progressive neurological diseases find they need additional support with eating
and drinking at mealtimes, and may require artificial nutrition and hydration. Decisions concerning artificial nutrition
and hydration at the end of life are ethically complex, particularly if the individual lacks decision-making capacity.
Decisions may concern issues of life and death: weighing the potential for increasing morbidity and prolonging
suffering, with potentially shortening life. When individuals lack decision-making capacity, the standard processes of
obtaining informed consent for medical interventions are disrupted. Increasingly multi-professional groups are being
utilised to make difficult ethical decisions within healthcare. This paper reports upon a service evaluation which
examined decision-making within a UK hospital Feeding Issues Multi-Professional Team.
Methods: A three month observation of a hospital-based multi-professional team concerning feeding issues, and
a one year examination of their records. The key research questions are: a) How are decisions made concerning
artificial nutrition for individuals at risk of lacking decision-making capacity? b) What are the key decision-making
factors that are balanced? c) Who is involved in the decision-making process?
Results: Decision-making was not a singular decision, but rather involved many different steps. Discussions
involving relatives and other clinicians, often took place outside of meetings. Topics of discussion varied but the
outcome relied upon balancing the information along four interdependent axes: (1) Risks, burdens and benefits;
(2) Treatment goals; (3) Normative ethical values; (4) Interested parties.
Conclusions: Decision-making was a dynamic ongoing process with many people involved. The multiple points
of decision-making, and the number of people involved with the decision-making process, mean the question of
‘who decides’ cannot be fully answered. There is a potential for anonymity of multiple decision-makers to arise. Decisions
in real world clinical practice may not fit precisely into a model of decision-making. The findings from this service
evaluation illustrate that within multi-professional team decision-making; decisions may contain elements of both
substituted and supported decision-making, and may be better represented as existing upon a continuum.
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Decision-making capacity
The concept of ‘decision-making capacity’ refers to a
person’s ability to understand, retain and balance infor-
mation, and communicate a choice [1]. It is a psycho-
logical construct which has been enshrined in law within
some countries, for example; in England and Wales,¹
and in Scotland.² Decision-making capacity can be af-
fected by many factors, such as: intoxication from the
consumption of alcohol, an acquired injury to the brain,
the presence of a developmental disability associated
with cognitive impairment, or the presence of a brain
disorder such as dementia. Loss of capacity can be tem-
porary, fluctuating or permanent.
Over the past ten years the concept of decision-
making capacity has grown in global significance, both
within medicine, and across law, research, social care
and human rights [2–4]. The number of individuals
who may have a disorder which puts them at risk of
lacking decision-making capacity is increasing as the
age of the global population rises [5]. Research under-
taken by Alzheimer’s Disease International predicts
that the current 36 million people living with demen-
tia will increase to 115 million by 2050 [6]. Advances
in healthcare have also resulted in increased life ex-
pectancy for those with severe intellectual disabilities,
[7] and those with acquired brain injuries such as
stroke, [8–10] many of whom will have impairments
in cognition and communication. Within high re-
source countries, improvements in medical treatments
have resulted in the increased survival of very low
birth weight babies, a proportion of whom will have
significant physical and cognitive impairments in child-
hood and later life [11, 12].
The United Nations Convention on the Rights of
Persons with Disabilities (UNCRPD) (2006)³ requires
signatory parties to protect and promote the full
human rights of persons with disabilities, including
those at risk of lacking decision-making capacity
[13]. The UNCRPD views disability through the lens
of human rights, Article 12 guarantees that persons
with disabilities, “enjoy legal capacity on an equal
basis with others in all aspects of life” (UNCRPD,
Article 12 (2)) [13]. This means that countries must
“provide access by persons with disabilities to the support
they may require in exercising their legal capacity”
(UNCRPD, Article 12 (3)) [13].
Decision-making in national and international law
Within one jurisdiction, England and Wales, the
Mental Capacity Act 2005 (MCA) provides a statutory
framework for how to proceed when people are judged
not to have the mental capacity to make a particular
decision. A person is only considered to be lackingdecision-making capacity for a particular decision if:
all practical steps have been taken without success,
they have a disorder or impairment of the brain or
mind, and are unable to: understand the relevant infor-
mation; retain the information; weigh the information;
communicate their decision [14]. Within Scotland,
decision-making is covered by the Adults With Incap-
acity (Scotland) Act (2000) [15]. Similarly, in most US
jurisdictions, individuals are expected to be able to
demonstrate four abilities to show decision-making
capacity: appreciate the nature and consequences of
their own situation; understand the relevant information;
be able to reason about potential risks and benefits; and
communicate a choice [16].
The Mental Capacity Act 2005 requires that any deci-
sion made for an individual is in accordance with their
‘best interests’. Best interests are defined broadly, in-
cluding: not making assumptions on the basis of age,
appearance, condition or behaviour [14]. Advance deci-
sions to refuse treatment (previously known as living
wills), must be followed if valid and applicable, even if
it may result in the person’s death [17]. Expressions of
treatment preferences, or ‘advance expressions of pref-
erences’ are not legally binding but should be incorpo-
rated as part of the decision-making process when
assessing “best interests” [17].
Some critics have argued that assessments of capacity
within the Mental Capacity Act 2005 may not be com-
pliant with the United Nations Convention on the Rights
of Persons with Disabilities (UNCRPD) [18, 19]. A
strong reading of Article 12 of the UNCRPD, rejects the
very concept of decision-making incompetence, arguing
that there is no point at which legal capacity should
be considered to be lost [18]. Such approaches push
the focus away from capacity testing and substituted
decision-making, towards an evaluative approach to
decision-making abilities, in which a person’s support
requirements for decision-making are determined and
then met [20].
Feeding issues at the end of life
Mealtimes are an important part of everyday life
[21, 22]. The sharing of food represents, not only a way
to sustain life, but also presents opportunities for
pleasure, comfort, socialising and maintaining family
and cultural identities [21, 23]. Individuals with cer-
tain conditions may find that they are unable to
participate in mealtimes. For example, people with de-
mentia, [24] intellectual disabilities [25] and acquired
brain injuries, [26, 27] can find they are unable to take
food and fluids orally, and/or may require additional
support during mealtimes. When this occurs, decisions
concerning artificial methods of nutrition and hydration
may be required.
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interventions which allow people to receive nutrients
and fluids through tubes directly into the digestive or
venous system [28]. These interventions may also be re-
ferred to as ‘clinically-assisted nutrition’, [29] ‘nutrition
support therapy’, [30] or ‘tube feeding’ [31]. Artificial
nutrition can be delivered directly into the gut, enteral
feeding; [28] or intravenously, parenteral feeding [32].
Common forms of artificial nutrition are: nasogastric
(NG), in which a narrow plastic tube is passed through
the nose into the stomach; and Percutaneous Endoscopic
Gastrostomy (PEG), in which a tube is inserted directly
into the stomach through the abdominal wall. Artificial
hydration can be provided intravenously or subcutane-
ously [29].
Decisions about artificial nutrition and hydration
Decisions about artificial nutrition and hydration con-
cern issues of life and death: weighing the potential for
increasing morbidity and prolonging suffering, with po-
tentially shortening life if no intervention takes place.
Competing human rights must be measured and bal-
anced, such as the right to life (European Convention on
Human Rights (ECHR), Article 2), and the right to free-
dom from degrading treatment (ECHR, Article 3).⁴ The
lack of a strong evidence base, particularly the dearth of
Randomised Control Trials (RCT), contributes to the
uncertainty in determining clinical outcomes [33]. For
some interventions, such as PEG, treatment decisions
can be particularly challenging. PEG insertions have
been associated with: futile procedures, [34] significant
mortality and morbidity rates, [34] and a lack of evidence
of benefit in certain patient groups, such as those with
advanced dementia [31]. These decisions are particu-
larly difficult when someone is approaching the end of
life, or when the individual lacks the mental capacity to
be involved in the decision themselves. As with all
medical treatments or interventions, the valid in-
formed consent of the patient is central, but many pa-
tients who may benefit from artificial nutrition and
hydration lack the decision-making capacity to consent
to the procedure [35].
Our previous systematic literature review found that
laws and healthcare practices concerning artificial nutri-
tion vary internationally, but only found four studies
which examined how decisions are made in practice
[36]. There is a dearth of evidence concerning how deci-
sions are made in real life clinical practice. This paper
takes a principlist approach, reflecting upon the four
classic principles of bioethical decision-making laid out
by Beauchamp and Childress [37] to examine decision-
making in practice within a UK hospital ‘Feeding Issues
Multi-Professional Team’, in circumstances in which the
‘patient voice’ was limited, and in some cases absent(such as where the person was unconscious). These
findings are then used to consider decision-making in
national and international law. The key research ques-
tions are:
a) How are decisions made concerning artificial nutrition
for individuals at risk of lacking decision-making
capacity?
b) What are the key decision-making factors that are
balanced?
c) Who is involved in the decision-making process?
Methods
Service evaluation setting and methods
A weekly non-participant overt observation of a UK hos-
pital Feeding Issues Multi-Professional Team (FIMPT)
over three months of a year, and a one year retrospective
study of the FIMPT records in 2011.
The FIMPT meets weekly to discuss patients with
complex feeding difficulties, it aims to improve decision-
making concerning assessment, treatment and clinical
outcomes. The team comprises medical members from
Gastroenterology, Palliative Care, Medicine for the
Elderly, Speech and Language Therapy, Dietetics, Nutri-
tion Clinical Nurse Specialists and Endoscopy Nurses.
The team meets for around one hour to discuss patients
referred each week. FIMPT meetings are part of normal
clinical practice, they are not held as ‘best interests’
proceedings.
Data collection and analysis
A thematic analysis approach was utilised for field-
work, data analysis and interpretation [38]. For the
first two months, detailed field notes on open
topics were taken. For the last month, a subset of
four meetings were sampled. These meetings were
audio recorded and analysed alongside the detailed
field notes. Notes were anonymised and the audio
recordings were transcribed and anonymised. All
notes and transcriptions were entered into NVivo 9
for analysis.
The thematic analysis was a six stage process: 1) Fa-
miliarisation with the data. The first author re-listened
to the audio recordings and read and re-read the tran-
scripts; 2) Initial coding stage. The transcripts were
coded using both open inductive data driven coding and
then coded using three broad categories derived from the
research questions; 3) Searching for themes. Initial codes
were discussed in team meetings between authors GC,
SB and AH. Insights from theory were discussed and
initial descriptive codes were developed into higher level
analytical themes. 4) Reviewing the themes. Themes were
reviewed and refined in an ongoing process of working
with data in NVivo and discussing the findings in team
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were refined and reviewed by discussion. These were
broadly separated into two over-arching themes; the
decision-making process model and the interdependent
decision-making axes, with 6 and 4 sub-themes respect-
ively. 6) Producing the report. Final themes were written
up to produce the paper which was reviewed and edited
by all authors.
The retrospective analysis of records was undertaken
using an electronic search of the hospital’s computer sys-
tem for all FIMPT reports in 2011. Data was extracted
into an anonymised form. Descriptive statistical analysis
was undertaken using PASW Statistics 17.
Ethics
After a review of the evaluation protocol by the
committee chair of the NHS Research Ethics Com-
mittee (REC) Cambridgeshire 2, it was agreed on 08/
03/2011 that the project was classed as a service
evaluation and would not require further review by
the REC. The researcher undertaking the fieldwork
applied for, and subsequent to review, was awarded
an honorary contract with the NHS Trust to undertake
this work. The honorary contract bound the researcher
to same standards of conduct and confidentiality as
paid employees of the NHS Trust. This evaluation was
carried out in compliance with the Helsinki Declar-
ation [39].
Anonymity, access and informed consent
To protect anonymity, the gender of all patients men-
tioned in this article has been redacted, and the year in
which the observational study was undertaken has been
removed. The observational study was not undertaken
in the same year as the records study. Quotations have
been edited to redact gender.
Access to the database utilised for the records study
is not publicly available. It is only available to em-
ployees of the NHS Trust in which it was stored. The
researcher accessing the database was bound by an
honorary contract when she undertook the fieldwork.
Data was extracted and anonymised on the NHS Trust
premises.
After a review of the evaluation protocol, verbal con-
sent was taken from the core members of the FIMPT
team. After the analysis was completed, written in-
formed consent was taken from the core members of
the team for all anonymised quotations to be used in a
publication.
Results
Patient characteristics
The one year study of FIMPT records revealed that in
2011, there were 206 patients referred using thehospital’s internal computer system. Of these, there
were 158 separate patient cases and 48 re-referrals of a
patient previously presented within the year. Ages
ranged from 17 to 97 years, the mean age at referral
was 65 years. It was recorded that, of the 158 patients,
85 (54 %) were judged to have decision-making cap-
acity at all meetings, and 44 (30 %) lacked decision-
making capacity or had uncertain decision-making
capacity at one point in the decision-making process.
The remaining 16 % had no statement about capacity
in their record.
Most cases referred to the FIMPT were concerning
an individual diagnosed with cancer. A primary diag-
nosis of cancer represented 70 individuals (44 % of
all those referred) and 79 discussions held at meet-
ings (38 % of all discussions). The second largest
group to be referred were those who had been diag-
nosed with a Cerebral Vascular Accident (CVA).
CVA patients represented 14 individuals (9 % of all
those referred) and 24 discussions (12 % of all dis-
cussions) [35].
Over the one month sample of audio-recorded meet-
ings in a different year, 12 patients were referred and 17
separate discussions were held. The largest group to be
referred were those with a primary diagnosis of cancer
(5 individuals, 42 % of all those referred). The remaining
seven referred patients had primary diagnoses of: Cere-
bral Vascular Accident (CVA), Motor Neurone Disease
(MND), Parkinson’s Disease, heart condition/disease,
pneumonia, Down’s Syndrome with dementia, and un-
known with dementia. Of this subset of 12 patients, half
(50 %) had decision-making capacity throughout the en-
tire decision-making process. Five patients (42 %) had
no, or unclear decision-making capacity, at one point in
the decision-making process; or had no/unclear capacity
during the entire decision-making process. For one pa-
tient (8 %), no statement was made about their decision-
making capacity.
For the analysis of the decision-making process all pa-
tient cases, both with and without decision-making cap-
acity were analysed. For the analysis of factors involved
in making decisions for those without decision-making
capacity, the analysis focused upon only those cases
involving patients with no or unclear decision-making
capacity.
The decision-making process
The discussions of patient cases followed a similar format
at each meeting: 1) Forming the picture; 2) Identifying
the problem; 3) Discussion; 4) Outcome and planning.
(see Table 1).
Decision-making was not a singular decision about
one method of artificial nutrition, but rather a process of
problem-solving for patients who often had complex
Table 1 Cross-tabulation illustrating a model of the process of FIMPT decision-making based on a three month non-participant observation
Decision stage Observation Description
0. Before the meeting Not observed Patient referred from ward or community. Depending upon time of admission and time of referral:
the dietician, speech and language therapist, gastroenterologist and other relevant specialists
assess the patient. Decision-making capacity is assessed. Treatment options are talked over and
explained with the patient and/or next of kin.
1. Forming the picture Observed Background information about the patient’s case is presented by member of the clinical team who
knows the patient. Dietetics and speech & language therapy present the results from their assessments
2. Identifying the problem Observed If the reasons for the patient’s referral are apparent and their diagnosis is clear, the discussion can move
straight onto stage 3. In complex cases, the Chair and other participants will ask further questions of the
person presenting the case, the speech and language therapist, dietician and anyone else who has
examined the patient.
3. Discussion Observed A deeper conversation about potential treatments and interventions. Conversation seeks to balance
risks and benefits, other clinical issues, and includes ethical and social concerns. At this stage, the
discussion has a less structured format. Stage 3 continues until the weight of evidence for a particular
treatment option or course of action becomes apparent.
4. Outcome and planning Observed The Chair states the outcome of decision-making process and a brief discussion of treatment
scheduling and planning follows. For some patients the outcome involves direct patient assessment
by one of the FIMPT clinicians, this may include referral to palliative care or medicine for the elderly
teams to assist in all future management not only management of nutrition.
5. After the meeting Not observed The recommendations from the meeting are presented back to the patient and/or next of kin by the
treating team who have presented the patient at the meeting. Further discussions and decision-making
take place. Relevant scheduling and planning takes place. The treating team return to the next meeting
for further discussion if additional questions arise or if the patient’s condition changes.
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making was not just limited to team meetings. Patients
were assessed on the ward before and after presenta-
tion at the FIMPT meeting, including an assessment
of decision-making capacity. Discussions were on-
going, taking place both before and after the meetings.
These discussions involved the ward team, relatives, and
if possible, the patient themselves. This included review
by FIMPT consultants, which may be required to assess
technical aspects of tube placement, issues regarding
decision-making capacity, discussions regarding patient
place of care for outpatients, and on-going specialist pal-
liative care input providing symptom control and advance
care planning. For each individual patient, multiple treat-
ment options and interventions were considered: ranging
from continued observation, to changes in medication re-
gimes, to artificial nutrition surgical interventions such as
Percutaneous Endoscopic Gastrostomy (PEG).Table 2 Cross-tabulation illustrating a model of the decision-making ax
Decision-making axes Description
Risks, burdens and benefits Comparison and weighting of the differe
dangers, outcomes and side-effects.
Treatment goals The intended outcome, either specific to
for future care for the patient or the ove
Normative ethical values A balancing of actions in terms of ethica
well-being and/or longevity; and deonto
Interested parties Discussions incorporated the views of al
wishes, clinical team, relatives, etc.Balancing complex and multi-faceted decision-making factors
Decisions concerning artificial nutrition and hydration for
patients at risk of lacking decision-making capacity were
complex and multi-faceted. The topics of discussion varied
for each individual case but the outcome of decision-making
relied upon weighting and balancing the available informa-
tion along four different but interdependent axes: (1) Risks,
burdens and benefits; (2) Treatment goals; (3) Normative
ethical values; (4) Interested parties. (see Table 2). These axes
of decision-making are completely interdependent. For each
decision, all available information has to be weighted or con-
sidered in relation to each axes which in turn have to all be
considered and reconsidered in relation to one another.
(1) Risks, burdens and benefits
During the discussion of indicated treatments and in-
terventions, the risks, burdens and benefits of each po-
tential course of action were considered and balancedes upon which clinical information was weighted to make decisions
nt treatment options and interventions by their potential effectiveness,
a particular treatment/interventions, place (institution/home)
rall intended outcome.
l value. Actions in terms of their utilitarian value, i.e., increasing patient
logical value, i.e., it was a ‘good’ course of action regardless of outcome.
l involved stakeholders, which could include: the patient or their previous
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compared to each other:
Clinician 1: I wonder what the benefit of a PEG over
an NG would be for her/him?
Clinician 2: It’s just caring for it at home, I think.
Discussion of a patient with Down’s Syndrome and
dementia
Where possible, the lowest risk approach with the least
intervention was preferred:
Clinician 1: Yes, it may be that with recovering
from this infection s/he might even start feeding
her/himself.
Clinician 2: Though s/he hadn’t last time really…
Discussion of an elderly patient with pneumonia
and food refusal
In the process of these ongoing discussions, the bio-
ethical principles of non-maleficence and beneficence
were utilised. Rather than conflicting with each other,
the principles of non-maleficence and beneficence were
utilised in a method of constant comparison, to con-
tinuously reassess and reflect upon the options. Con-
sidering different interventions and their associated
risks, burdens and benefits was not a singular decision
but rather an on-going process as the patient’s condi-
tion changed and dependent upon their circumstances.
Acute issues, such as infections, were considered with
the most urgency, but social and environmental factors
were also taken into consideration. For example, the
risks of treatments were considered both in terms of
contraindications and in relation to the social environ-
ment the patient would be discharged to:
I think it would also be worth getting another opinion
from old-age psychiatry before s/he goes, to see if
they’ve got any other suggestions about behaviour
management, because it’s going to be very difficult for
the family on the days that s/he refuses and they’re
anxious at home. And if s/he gets another infection
and won’t take any treatment, s/he’s going to end up
back in here, isn’t s/he?
Discussion of an elderly patient with pneumonia
and food refusal
(2) Treatment goals
Risks and benefits were considered in relation to the
overall treatment goals and intended health out-
comes which could change as an individual’s condi-
tion developed and was reassessed. Treatment goals
could be intervention specific, or broader relating to
improvements in longevity and quality of life. Thesewere not mutually exclusive goals. Rather, longevity
and quality of life were both always important, but
their weighting depended largely upon the individual
patient’s prognosis. Although this in itself was not
deterministic:
Is s/he coming to the end of her/his life? You know, the
bad days are getting worse and more frequent, s/he’s
doing less well. It doesn’t necessarily mean s/he
doesn’t… shouldn’t, have a PEG. But it’s the whole end
of life planning, isn’t it? And the difficulty in feeding is
just one aspect of it.
Discussion of a patient with Parkinson’s Disease
For patients with treatable disease, or chronic long-
term conditions, the focus was on extending life. Feed-
ing interventions had to be aligned with disease altering
treatments. Where it appeared that an individual may
be coming to the end of their life, and the course of ac-
tion was agreed with relatives and clinical team respon-
sible, a greater emphasis was placed upon enhancing
quality life.
Clinician 1: Would we be improving the quality or the
quantity of her/his life by giving her a PEG?
Clinician 2: Well, that’s a very difficult question…
Discussion of a patient with Down’s Syndrome and
dementia
Quality of life was conceptualised broadly and in-
cluded balancing multiple clinical and non-clinical fac-
tors. Factors considered when assessing quality of life
included weighing the ability to enjoy mealtimes and the
taste of food with reducing the risk of aspiration:
Is actually eating something giving her/him pleasure?
…so the tastes, plus the risk of aspiration might be
preferable?
Discussion of a patient with Down’s Syndrome and
dementiaClinician 1: S/he’s just refusing all food at the moment.
Clinician 2: Except on a good day, when s/he eats
everything.
Clinician 1: On Monday, s/he ate everything.
Clinician 2: Is it the taste, do you think?
Clinician 1: Well, we’ve tried getting… we originally
thought it was, so we got her/his family to bring in
some really strongly-flavoured curries. S/he loves
her/his Guinness and we prescribed Guinness, and
on a good day, s/he’ll take that. S/he’ll happily drink
that and you don’t even need to encourage her/him
very much. But on a day when s/he doesn’t feel like
doing anything, s/he just won’t, not even Guinness
Clarke et al. BMC Medical Ethics  (2015) 16:41 Page 7 of 11or her/his family’s encouragement will induce
her/him to eat.
Discussion of an elderly patient with pneumonia
and food refusal
Quality of life was also seen to be enhanced by meal-
times with family, and spoon-feeding undertaken by rel-
atives, was perceived as positive social interaction that
could increase the individual’s quality of life. The impact
of having a PEG fitted, and not being able to take food
orally, was balanced against social interaction:
Clinician 1: What does the patient have to gain by
feeding in a different way from how s/he’s been
apparently successfully fed all this length of time at
home, without the recurrent aspiration pneumonias?
Clinician 2: The consultant yesterday said that he
felt s/he still had some quality of life in the
interactions that s/he shares with her/his family.
And I think they were suggesting PEG as an option
to kind of try and avoid the aspirations that might
possibly occur…
Clinician 1: It doesn’t necessarily though, does it?
Clinician 2: No. Exactly.
Clinician 1: Especially if s/he’s lying flat on her/his
back… And your description it sounds as if the
interaction s/he has with her/his family is when they
sit her/him up, wake her/him up to feed he/him
Discussion of a patient with Down’s Syndrome and
dementia
Clinician 1: But at the moment s/he doesn’t really
have any interaction with her/his family even?
Clinician 2: Well, s/he talks to her/his family.
Clinician 1: And s/he will, s/he’ll drink with them, s/
he refuses most other times but they’re trying to get
her/him to eat but so far s/he’s refused.
Discussion of an elderly patient with pneumonia
and food refusal
A stimulating and interesting environment was also
considered important, for both inpatients, and after be-
ing discharged:
S/he’d come from a side room because of her/his C Diff
and they’re hoping that s/he’ll find the bay a bit more
stimulating and s/he’ll get on a bit better, so I think
what they were hoping was to give her/him one more
try with an NG with antidepressants.
Discussion of an elderly patient with dementia
Before admission… s/he had a pretty good quality of
life, s/he lives with her/his extended, very supportive
family who are keen that s/he stays at home andwouldn’t want nursing home influence, so it was
really just a question of how we could best manage
her/him.
Discussion of an elderly patient with pneumonia
and food refusal
A central quality of life factor was freedom from pain
and discomfort. Family members particularly voiced this
concern for their relative. Although family members did
not attend FIMPT meetings, family views were sought
by the treating team, and raised at the meetings for
patient’s lacking capacity:
S/he does have family, they’ve been a bit concerned,
and originally they were sort of reluctant about an
NG. They had the impression that it was cruel, and
not the right thing to do.
Discussion of an elderly patient with dementia
(3) Normative ethical values
Any treatment or course of action was balanced in terms
of its normative ethical values. Treatment options were
balanced between those that had a utilitarian value, in
that they increased patient well-being, prevented harm
or helped a course of treatment proceed; and those ac-
tions that had a deontological value, in that they were a
‘good’ in themselves regardless of outcome. Decision-
making was easier in the cases in which the normative
values aligned. For example, when making the decision
to spoon feed a patient:
Clinician 1: And have we actually had a try of sitting
there with a teaspoon?
Clinician 2: I think that’s what the hope is that when
s/he’s on [Ward name] perhaps a little bit more time
to do that.
Discussion of an elderly patient with dementia
In this scenario, food as nourishment to improve the
patient’s health and physical condition align with food
and social contact through spoon-feeding as pleasure
and enjoyment to maximise the patient’s wellbeing. How-
ever, when the value of food as pleasure conflicts with the
aims of improving the patient’s health and well-being, it is
clear that decisions are not just being made to maximise
overall utilitarian values. For example, when inserting a
PEG feeding tube was considered:
Clinician 1: Yeah, the husband/wife did also mention
about the medication that it would be easier for them
to administer medication through the PEG…
Clinician 2: So it would take a bit of the burden off
them worrying about it.
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completely for nutrition but initially to supplement it,
um, but actually use it basically for medications, that
was also brought up by her/his husband/wife.
Discussion of a patient with Parkinson’s Disease
In this scenario, despite the risk of choking, some
oral feeding will still take place. Food as pleasure and
social contact through oral feeding have become val-
ued as intrinsic goods within themselves, regardless of
the potential consequences i.e., that oral feeding could
ultimately lead to choking and the patient’s early
death. Decisions are no longer just about maximising
overall utility, they are made more difficult because of
the conflict between the utilitarian values of prevent-
ing aspiration and administering medicine with ease,
and the intrinsic good of being able to enjoy food and
family mealtimes
(4) Interested parties
The meetings were not the sole locus of decision-
making. Decisions also involved: the clinical team treat-
ing the patient; relatives, often spouses or children; and
if possible, the patient’s previous or interpreted wishes.
Discussions held at the FIMPT had to incorporate the
views of all these interested parties. The treating clinical
team were usually represented at the meetings, but fam-
ily members were not. Instead, in-depth conversations
were sought before and after. Communication with fam-
ily was two-way; relatives’ views on treatment decisions
were sought and clinicians would feedback about poten-
tial interventions:
Yeah. I mean, I can certainly talk to the family and give
them a call or hopefully they’ll be in next time I review
the patient and go through those options in more detail.
Discussion of a patient with Down’s Syndrome and
dementia
I know there were discussions, it was raised in the last
meeting about the possibility of a PEG and I think,
from her/his family’s point of view, I think this is
something that they would like, because they obviously
want her/him to be at home, they want her/him to be
out of hospital and, from her/his point of view, it’s
tricky, because as with most of his care, sometimes
s/he’ll say “Yes, that’s fine, I want to do that” and
sometimes s/he will refuse everything.
Discussion of an elderly patient with pneumonia
and food refusal
Sometimes this involved managing relatives’ expecta-
tions about what could be achieved through artificial
feeding interventions:Clinician 2: Her/his BMIs?
Clinician 1: Twenty-six, so…
Clinician 2: Yeah, it’s fine. So, s/he’s not
malnourished, so we’d just be maintaining her/him
whilst her/his disease got worse. So it’s making sure
they understand that.
Discussion of a patient with Parkinson’s Disease
Family interactions were also important in terms of
care planning, particularly if the patient lived with family
members. Though the living situation of a patient did
not dictate whether a form of artificial nutrition was rec-
ommended or not, family relationships were discussed
as part of the decision-making process. Where appropri-
ate the patient was not just treated as an individual but
also as part of a family unit.
We just need to train and just need to find out the
situation with her/his family actually, you know, in
terms of… the reality is, how much they actually want
to take on and in terms of there would need to be a
care package put together and we’d need to get the
carers trained, so I think, yeah.
Discussion of an elderly patient with pneumonia
and food refusal
Patient’s own wishes could be incorporated into the
decision-making if they were available. However, none of
the individuals referred to FIMPT during the three
month period had made Advance Decisions to Refuse
Treatment (ADRT) related to feeding interventions. One
individual with decision-making capacity and Motor
Neurone Disease, had made an advanced expression of
treatment preference regarding Percutaneous Endoscopic
Gastrostomy.
Patient’s informal wishes about interventions were
sought through relatives, where they were available:
I think we need to know what her/his family think,
if the family know what her/his views would be,
not that that determines what we do, but we need
to take that into account, if there’s any way of
understanding if s/he can swallow or not but I
think probably we wouldn’t be able to do that
because s/he’s drowsy…
Discussion of an elderly patient with dementia
In the majority of cases, no formal or informal infor-
mation was available about what a patient might want.
In these cases, where appropriate, an interpretation of
the patient’s behaviour was considered. For example, in
the case of an elderly patient with dementia who has
stopped eating and drinking, the meaning of this behav-
iour is discussed:
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her/his….coming to the end of her/his life that’s part
of it? Or as part of dementia? And if it’s a case of we
think s/he’s really depressed and needs antidepressants
then tube feeding is probably inappropriate?
Discussion of an elderly patient with dementia
In another case, the meaning of an elderly patient re-
fusing food and water is considered:
I think her/his family felt that it was more of a fear of
choking or aspirating that was preventing her/him
because that’s what s/he told before s/he was ill, that
s/he was scared, I don’t know whether that’s
contributing to her/his food refusal still.
Discussion of an elderly patient with pneumonia
and food refusal
Through these kinds of discussions, the bioethical
principle ‘respect for autonomy’ was realised, despite the
patient not being fully autonomous, or having decision-
making capacity themselves.
Discussion
This service evaluation of a Feeding Issues Multi-
Professional Team (FIMPT) based within a UK hospital
has revealed that decision-making concerning feeding
interventions for individuals who lack capacity is a dy-
namic and complex process. The decision-making was
not a one-off choice, but rather involved many different
steps and many decisions. Discussions involving relatives
and other clinicians, were also part of the process, taking
place both before and after team meetings. The decision-
making process evolved as the patient’s condition chan-
ged; sometimes involving re-referring and re-discussion at
FIMPT meetings.
Rather than a specific set of decision-making factors
or criteria which can be applied to each case, decision-
making is better conceptualised as process of weighing
and balancing information on the inter-related axes of:
(1) Risks, burdens and benefits; (2) Treatment goals; (3)
Normative ethical actions; (4) Interested parties. How-
ever, there were some key issues discussed across many
of the cases: acute issues were given the greatest weight,
but wider social and environmental were also taken into
account; and quality and length of life were always both
considered. Key quality of life factors included pleasure of
food versus risk of aspiration, social contact time versus
ease of feeding and medication administration; freedom
from pain and discomfort versus not prolonging suffering.
When individuals lack decision-making capacity and
are unable to give informed consent, the usual ethical
processes of medical procedures are disrupted. However,
even though the individuals were not fully autonomous,within this example of decision-making, the principle of
‘respect for autonomy’ was still partially realised as pa-
tients’ behaviour was taken into account, and clinicians
spoke to patients’ relatives. As ‘respect for autonomy’ could
not be fully utilised, the principles of non-maleficence and
beneficence gained greater significance. Non-maleficence
and beneficence were utilised through constant compari-
son in verbal group reasoning, allowing discussions about
treatment goals, risks, burdens and benefits. The fourth
bioethical principle of ‘justice’ was not utilised within the
discussions, as each case was considered on its own terms,
and not in relation to other patients or to resource man-
agement. Balancing the normative ethical values made
decision-making easier. When a utilitarian course of ac-
tion, also had deontological value, less debate was required
about the course of action.
The observational study revealed a complex and often
‘messy’ reality of decision-making in the real world; deci-
sions were always ongoing, involving multiple recom-
mendations and decision-makers. The findings from this
study reveal there is no clear distinction between sup-
ported and substituted decision-making, because in real
world clinical practice decisions do not exist in isolation:
decisions involved multiple stages; some of which in-
volved substituted decisions, such as deciding which
treatments to recommend; and some of which involved
supported decision-making such as taking into account
a patient’s behaviours, even if they didn’t have full
decision-making capacity. Perhaps the distinction be-
tween substituted and supported decision-making could
be better conceptualised as a sliding scale, in which parts
of decisions requiring substitution decisions should al-
ways be in a patient’s ‘best interests’, but capacity should
also be maximised for supporting decisions at the same
time. The recent report by the House of Lords on the
Mental Capacity Act, criticised the lack of implementation
[40]. The findings from this observational study show the
complexity of real world clinical decision-making. This
may go some way to explaining the difficulties of im-
plementation of the MCA. The findings also reveal the
importance and robustness of multi-professional dis-
cussions in these settings, the same level of debate
could not be achieved by a uni-professional discussion.
This paper reports upon a small scale service evalu-
ation. Further research could examine these models of
decision-making in other clinical settings.
Conclusions
Decisions regarding eating and drinking interventions at
the end of life are serious. In particular, decisions sur-
rounding stopping oral feeding and inserting feeding
tubes, The decision to intervene, or not intervene, with
feeding is ethically and clinically challenging, and often oc-
curs under grave circumstances. Team meetings addressed
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the framework of the Mental Capacity Act 2005, which re-
quires decision-makers to act according to the patient’s
best interests. The perspectives of different disciplines con-
cerning what might be the most appropriate course of ac-
tion were encouraged and sought during discussions.
Decision-making regarding feeding interventions in-
volves multiple decision-makers and decision points,
and it is acknowledged that the study has not addressed
all of these, or seen the entire picture. The ward consult-
ant responsible for the patient’s care was not usually
present at the meeting, often the case was present by a
junior medical member of their team. The study did not
address how decision-making capacity had been assessed
by the ward team, or how it was reviewed by the FIMPT,
or information was relayed to patients and their families.
For decisions concerning the insertion of percutaneous
endoscopic gastrostomy (PEG), the consultant who would
potentially insert the PEG was present. However, the study
did not include subsequent consultations with patient and
family after the team meeting to explain the decision to
proceed with an intervention and obtain informed consent
or assent. The multiple points of decision-making, and the
number of people involved with the decision-making
process, mean the question of ‘who decides’ cannot be
fully answered. There is a potential for anonymity of mul-
tiple decision-makers to arise. While the meetings operate
within the Mental Capacity Act 2005 (MCA), what the
paper describes does not constitute a ‘best interests pro-
ceeding’ under the MCA, instead it is part of routine clin-
ical practice. The team did not assess decision-making
capacity at meetings, but did review the assessments. Pa-
tient’s relatives did not attend the meetings, but rather
their views were sought. The team were one-step removed
from the patient’s bedside, and thus unable to make best
interests decisions. It could be reasoned that the team
meetings made healthcare or “medical best interest” deci-
sions, deciding on the right medical treatment while using
MCA ‘best interests’ language.
Some legal interpretations of the United Nations
Convention on the Rights of Persons with Disabilities
(UNCRPD), argue that under the UNCRPD there is no
point at which legal decision-making capacity is lost,
and thus all decisions must be supported, rather than
substituted [18–20]. Under the Mental Capacity Act
2005, legal capacity testing represents a ‘cut-off point’ for
a decision, and creates a categorical distinction between
supported and substituted decision-making. This study
has illustrated that, in clinical practice, decisions may
contain elements of both substituted and supported
decision-making, often moving backwards and forwards
between the two. Substituted and supported decision-
making may be better represented as existing on a
continuum.Endnotes
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